A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participants

被引:24
作者
Byberg, S. [1 ,2 ,3 ]
Thysen, S. M. [1 ,2 ,4 ]
Rodrigues, A. [1 ]
Martins, C. [1 ]
Cabral, C. [1 ]
Careme, M. [1 ]
Aaby, P. [1 ,2 ]
Benn, C. S. [1 ,2 ,3 ]
Fisker, A. B. [1 ,2 ,3 ]
机构
[1] Indepth Network, Bandim Hlth Project, Apartado 861, Bissau 1004, Guinea Bissau
[2] Statens Serum Inst, Res Ctr Vitamins & Vaccines CVIVA, Bandim Hlth Project, Artillerivej 5, DK-2300 Copenhagen S, Denmark
[3] Univ Southern Denmark, Inst Clin Res, Odense Univ Hosp, OPEN,Odense Patient Data Explorat Network, DK-5000 Odense C, Denmark
[4] Aarhus Univ, Dept Publ Hlth, Ctr Global Hlth, DK-8000 Aarhus C, Denmark
基金
欧洲研究理事会; 新加坡国家研究基金会;
关键词
Measles vaccine; Measles vaccination campaign; Non-specific/heterologous effects; Guinea-Bissau; Child survival; Supplementary immunization activities; VITAMIN-A SUPPLEMENTATION; IMMUNIZATION; SURVIVAL; VACCINES; IMPACT;
D O I
10.1016/j.vaccine.2016.11.049
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Measles vaccination campaigns targeting children aged 9-59 months are conducted every three years in Guinea-Bissau. Studies have demonstrated beneficial non-specific effects of measles vaccine. We compared mortality one year after the December 2012 measles vaccination campaign in Bissau city for children who received campaign measles vaccine with children who did not receive campaign measles vaccine. Methods: Field workers from Bandim Health Project registered all children living in the Bandim Health Project's study area who received measles vaccination at the campaign posts. Children not seen during the campaign were visited at home and campaign participation status was assessed. We compared mortality rates of participants vs. non-participants in Cox regression models. Results: 5633 children aged 9-59 months (85%) received campaign measles vaccination and 1006 (15%) did not. During the subsequent year 16 children died. Adjusted for background factors, the hazard ratio (HR) comparing measles vaccinated versus unvaccinated was 0.28 (95% CI: 0.10-0.77). The benefit was larger for girls (HR: 0.17 (0.05-0.59)) and for children who had received routine measles vaccine before the campaign (HR: 0.15 (0.04-0.63)). Conclusions: We found indications of strong beneficial non-specific effects of receiving measles vaccine during the 2012 campaign, especially for girls and children with previous routine measles vaccination. Measles vaccination campaigns may be an effective way of improving child survival. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 26 条
[1]   REDUCED CHILDHOOD MORTALITY AFTER STANDARD MEASLES VACCINATION AT 4-8 MONTHS COMPARED WITH 9-11 MONTHS OF AGE [J].
AABY, P ;
ANDERSEN, M ;
SODEMANN, M ;
JAKOBSEN, M ;
GOMES, J ;
FERNANDES, M .
BRITISH MEDICAL JOURNAL, 1993, 307 (6915) :1308-1311
[2]   NONSPECIFIC BENEFICIAL EFFECT OF MEASLES IMMUNIZATION - ANALYSIS OF MORTALITY STUDIES FROM DEVELOPING-COUNTRIES [J].
AABY, P ;
SAMB, B ;
SIMONDON, F ;
SECK, AMC ;
KNUDSEN, K ;
WHITTLE, H .
BRITISH MEDICAL JOURNAL, 1995, 311 (7003) :481-485
[3]   Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation:: an unplanned study [J].
Aaby, P ;
Garly, ML ;
Balé, C ;
Martins, C ;
Jensen, H ;
Lisse, I ;
Whittle, H .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (09) :798-805
[4]   Measles Vaccination in the Presence or Absence of Maternal Measles Antibody: Impact on Child Survival [J].
Aaby, Peter ;
Martins, Cesario L. ;
Garly, May-Lill ;
Andersen, Andreas ;
Fisker, Ane B. ;
Claesson, Mogens H. ;
Ravn, Henrik ;
Rodrigues, Amabelia ;
Whittle, Hilton C. ;
Benn, Christine S. .
CLINICAL INFECTIOUS DISEASES, 2014, 59 (04) :484-492
[5]   Non-specific and sex-differential effects of routine vaccines What evidence is needed to take these effects into consideration in low-income countries? [J].
Aaby, Peter ;
Benn, Christine S. .
HUMAN VACCINES, 2011, 7 (01) :120-124
[6]   Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial [J].
Aaby, Peter ;
Martins, Cesario L. ;
Garly, May-Lill ;
Bale, Carlito ;
Andersen, Andreas ;
Rodrigues, Amabelia ;
Ravn, Henrik ;
Lisse, Ida M. ;
Benn, Christine S. ;
Whittle, Hilton C. .
BMJ-BRITISH MEDICAL JOURNAL, 2010, 341 :1262
[7]  
[Anonymous], 2009, Wkly Epidemiol Rec, V84, P349
[8]  
[Anonymous], 2014, SYSTEMATIC REV NONSP
[9]  
[Anonymous], COMPR MULT PLAN EXP
[10]  
[Anonymous], NATL IMMUNIZATION CA, DOI DOI 10.1097/INF.0000000000000896